- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05268133
Aronia and Cognitive Fitness
Aronia and Cognitive Fitness: Focus on Brain Insulin-Sensitivity and Vascular Function
Previously, beneficial effects of Aronia Melanocarpa extract (AME) supplementation on cognitive performance has been observed in healthy middle-aged adults. However, underlying mechanisms have not yet been addressed. In addition, effects of AME are unknown in subjects at increased risk of cognitive impairment. It is hypothesized that supplementation with AME enhances (regional) brain vascular function and brain insulin-sensitivity, thereby improving cognitive function of subjects at increased risk of cognitive impairment.
The primary objectives are to investigate effects of AME intake on brain vascular function and insulin-sensitivity in cognitive-control brain areas, while we will also evaluate changes in cognitive function (secondary objective).
The present study is a randomized, double-blind, placebo-controlled, cross-over trial consisting of two study groups and a pre- and post-test day in both study arms.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Maastricht, Netherlands
- Metabolic Research Unit Maastricht
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Men and women, aged between 55-75 years
- BMI between 25-35 kg/m2
- Fasting plasma glucose < 7.0 mmol/L
- Fasting serum total cholesterol < 8.0 mmol/L
- Fasting serum triacylglycerol < 4.5 mmol/L
- Systolic blood pressure < 160 mmHg and diastolic blood pressure < 100 mmHg
- Stable body weight (weight gain or loss < 3 kg in the past three months)
- Willingness to give up being a blood donor from 8 weeks before the start of the study, during the study and for 4 weeks after completion of the study
- No difficult venipuncture as evidenced during the screening visit
Exclusion Criteria:
- Smoking or smoking cessation < 12 months
- Presence of diabetes mellitus
- Active cardiovascular disease like congestive heart failure or cardiovascular event
- Severe medical conditions, including asthma, chronic obstructive pulmonary disease (COPD), kidney failure, auto-inflammatory diseases or rheumatoid arthritis
- Unstable body weight (weight gain or loss > 3 kg in the past three months)
- Use of dietary supplements or medication affecting the main outcomes of the study
- Use of an investigational product within another biomedical intervention trial within the previous month
- Contra-indications for MRI imaging (e.g., pacemaker, surgical clips/material in body, metal splinter in eye, claustrophobia)
- Left-handedness
- Familial hypercholesterolemia
- Abuse of drugs
- More than 3 alcoholic consumptions per day
- Use medication to treat blood pressure, lipid or glucose metabolism
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Aronia
An aronia melanocarpa extract.
Study volunteers will receive a daily oral dose of 160 mg AME for 6 weeks.
|
As described in experimental arm
|
Placebo Comparator: Control
Cellulose.
Study volunteers will receive a daily oral dose of 160 mg cellulose for 6 weeks.
|
As described in placebo comparator arm
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Brain Vascular function
Time Frame: Change after 6 weeks of intervention
|
cerebral blood flow as quantified non-invasively by the MRI perfusion method arterial spin labeling (ASL MRI).
Higher cerebral blood flow indicates improved brain vascular function.
|
Change after 6 weeks of intervention
|
Brain insulin sensitivity
Time Frame: Change after 6 weeks of intervention
|
cerebral blood flow as quantified non-invasively by the MRI perfusion method arterial spin labeling (ASL MRI) before and after application of intranasal insulin (160 IU). Higher cerebral blood flow after intranasal insulin application indicates improved brain insulin sensitivity |
Change after 6 weeks of intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cognitive performance
Time Frame: Change after 6 weeks of intervention
|
Quantified through the Cambridge Neuropsychological Test Automated Battery (CANTAB).
|
Change after 6 weeks of intervention
|
Collaborators and Investigators
Investigators
- Principal Investigator: Peter J Joris, PhD, Maastricht University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- METC 21-084
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cognition
-
Hasselt UniversityRecruiting
-
Geriatric Education and Research InstituteNeeuro Pte LtdCompleted
-
University of NebraskaCompleted
-
Indiana UniversityAmerican Egg BoardWithdrawn
-
University Hospital, Clermont-FerrandUniversité d'AuvergneCompleted
-
University of MinnesotaWithdrawn
-
United States Army Aeromedical Research LaboratoryUnknownCognitionUnited States
-
University College CorkUnknown
-
The University of New South WalesCompleted
-
Huashan HospitalChinese Academy of SciencesNot yet recruiting
Clinical Trials on Aronia
-
University of AarhusActive, not recruiting
-
University of AarhusCompletedBioavailabilityDenmark
-
Odense University HospitalCompleted
-
Maastricht University Medical CenterBioActor B.V.Completed
-
University of BelgradeClinical Hospital Center ZemunUnknownHypertension | OverweightSerbia
-
University of North DakotaUSDA Grand Forks Human Nutrition Research Center; Altru Health SystemCompletedInflammation | Oxidative Stress | Mental Health Wellness 1United States
-
Maastricht University Medical CenterBioActor B.V.Recruiting
-
King's College LondonNaturex-DbsCompleted
-
Colorado State UniversityNaturex-DbsCompletedAging | Endothelial DysfunctionUnited States
-
Maastricht University Medical CenterBioActorRecruiting